SCHEMBL25826792

SCHEMBL25826792

COCCCCCCOCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.63
TDP1 Q9NUW8 1/20 0.63
TSHR P16473 1/20 0.54
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.46
HRH4 Q9H3N8 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
GBA1 P04062 2/20 0.43
UGCG Q16739 2/20 0.43
GBA2 Q9HCG7 2/20 0.43
EPHX2 P34913 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NAAA Q02083 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4162511 1.00 L3MBTL1 (0.63) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL18898775 1.00 L3MBTL1 (0.63) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL15923313 1.00 L3MBTL1 (0.63) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL12561325 0.98 L3MBTL1 (0.60) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL21215156 0.94 L3MBTL1 (0.57) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL16845882 0.94 TSHR (0.56) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL13909725 0.90 L3MBTL1 (0.57) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL9011646 0.89 TSHR (0.67) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL9011624 0.89 TSHR (0.67) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL9011734 0.89 TSHR (0.67) L3MBTL1TDP1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129564-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2023-07-06 WO disclosed